Use of Real-World Data in Systematic Literature Reviews Conducted for Health Technology Assessment Submissions in Europe

被引:0
|
作者
Dasari, G. [1 ]
Mulkalapalli, N. [2 ]
Bongale, A. A. [2 ]
Rajput, A. [3 ]
Kamra, S. [3 ]
Gaultney, J. [4 ]
机构
[1] IQVIA, Hyderabad, AP, India
[2] IQVIA, Bangalore, AP, India
[3] IQVIA, Gurugram, India
[4] IQVIA, London, England
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
HTA206
引用
下载
收藏
页码:S337 / S337
页数:1
相关论文
共 50 条
  • [1] UTILITY OF ARTIFICIAL INTELLIGENCE IN SYSTEMATIC LITERATURE REVIEWS FOR HEALTH TECHNOLOGY ASSESSMENT SUBMISSIONS
    Cichewicz, A.
    Burnett, H.
    Huelin, R.
    Kadambi, A.
    VALUE IN HEALTH, 2022, 25 (07) : S604 - S604
  • [2] USE OF REAL-WORLD DATA IN REGULATORY AND REIMBURSEMENT SUBMISSIONS FOR PERSONALIZED MEDICINES IN EUROPE
    Chagneau, C.
    Bianic, F.
    Guelfucci, F.
    Sysavath, C.
    Vossen, C.
    VALUE IN HEALTH, 2022, 25 (12) : S270 - S270
  • [3] The inclusion of real-world data in health technology assessment submissions is associated with a higher likelihood of positive decisions
    Qian, Christina J.
    Deighton, Alison M.
    Harwood, Meagan M.
    Mickle, Alexis T.
    Szabo, Shelagh M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 558 - 559
  • [4] Why is target trial emulation not being used in health technology assessment real-world data submissions?
    Castanon, Alejandra
    Duffield, Stephen
    Ramagopalan, Sreeram
    Reynolds, Robert
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2024, 13 (08)
  • [5] Why is target trial emulation not being used in health technology assessment real-world data submissions?
    Castanon, Alejandra
    Duffield, Stephen
    Ramagopalan, Sreeram
    Reynolds, Robert
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2024,
  • [6] The use of real-world data/evidence in regulatory submissions
    Song, Fuyu
    Zang, Chenxuan
    Ma, Xinyi
    Hu, Sifan
    Sun, Qiqing
    Chow, Shein-Chung
    Sun, Hongqiang
    CONTEMPORARY CLINICAL TRIALS, 2021, 109
  • [7] Real-world data for efficient health technology assessment
    Hall, Peter S.
    EUROPEAN JOURNAL OF CANCER, 2017, 79 : 235 - 237
  • [8] THE USE OF REAL-WORLD DATA IN HEALTH TECHNOLOGY ASSESSMENT OF MEDICATIONS FOR RARE DISEASES
    Harwood, M.
    Deighton, A.
    Mickle, A.
    Qian, C.
    Szabo, S.
    VALUE IN HEALTH, 2019, 22 : S863 - S863
  • [9] The use of real-world data in health technology assessment of medications for rare diseases
    Qian, Christina J.
    Mickle, Alexis T.
    Deighton, Alison M.
    Harwood, Meagan M.
    Szabo, Shelagh M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 259 - 259
  • [10] The use of Real-World Data (RWD) by Health Technology Assessment (HTA) agencies
    Karen, K.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2021, 31 : 218 - 218